The role of barriers to care on the propensity for hepatitis C virus nonreferral among people living with HIV
Twenty-five percent of HIV/hepatitis C virus (HCV) coinfected patients were not referred for HCV treatment despite unrestricted access in California to direct-acting antivirals (DAA) in 2018. Having unstable housing and ongoing drug use directly affected HCV treatment nonreferral. However, psychiatr...
Gespeichert in:
| Veröffentlicht in: | AIDS (London) 2020-09, Vol.34 (11), p.1681-1683 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1683 |
|---|---|
| container_issue | 11 |
| container_start_page | 1681 |
| container_title | AIDS (London) |
| container_volume | 34 |
| creator | Cachay, Edward R. Torriani, Francesca J. Hill, Lucas Jain, Sonia Del Real, Azucena Qin, Huifang Martin, Natasha Mathews, William C. |
| description | Twenty-five percent of HIV/hepatitis C virus (HCV) coinfected patients were not referred for HCV treatment despite unrestricted access in California to direct-acting antivirals (DAA) in 2018. Having unstable housing and ongoing drug use directly affected HCV treatment nonreferral. However, psychiatric history and alcohol use impacted HCV treatment nonreferral through the mediation of not being engaged in HIV care. Achieving HCV elimination requires DAA treatment outside conventional health settings, including substance rehabilitation centers, mental health crisis houses, and homeless shelters. |
| doi_str_mv | 10.1097/QAD.0000000000002610 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_QAD_0000000000002610</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32769765</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3982-63fbaa56c47a752bbd3d53a81c945c9b84516ae079524a7403c1a9d49082b2363</originalsourceid><addsrcrecordid>eNpdkGtLwzAUhoMobk7_gUj-QGeuTfNxzMsGAxGmX0vapjbaNiXJNvbvjc4bni-H857zvhweAC4xmmIkxfXj7GaK_hRJMToCY8wETTgX-BiMoyYTSQUagTPvX-MRR1l2CkaUiFSKlI9Bt240dLbV0NawUM4Z7TwMFpbKRa2HIe4HZwfdexP2sLYONnpQwQTj4Rxujdt42Nve6Vo7p1qoOtu_wEHbIYa2ZmvitDOhgYvl8zk4qVXr9cVXn4Cnu9v1fJGsHu6X89kqKanMSJLSulCKpyUTSnBSFBWtOFUZLiXjpSwyxnGqNBKSE6YEQ7TESlZMoowUhKZ0Atght3TW-_haPjjTKbfPMco_6OWRXv6fXrRdHWzDpuh09WP6xvWbu7NtiKDe2s1Ou7zRqg3NZx5BFCUkNiQRRklUMKHv-aN6Jw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The role of barriers to care on the propensity for hepatitis C virus nonreferral among people living with HIV</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Cachay, Edward R. ; Torriani, Francesca J. ; Hill, Lucas ; Jain, Sonia ; Del Real, Azucena ; Qin, Huifang ; Martin, Natasha ; Mathews, William C.</creator><creatorcontrib>Cachay, Edward R. ; Torriani, Francesca J. ; Hill, Lucas ; Jain, Sonia ; Del Real, Azucena ; Qin, Huifang ; Martin, Natasha ; Mathews, William C.</creatorcontrib><description>Twenty-five percent of HIV/hepatitis C virus (HCV) coinfected patients were not referred for HCV treatment despite unrestricted access in California to direct-acting antivirals (DAA) in 2018. Having unstable housing and ongoing drug use directly affected HCV treatment nonreferral. However, psychiatric history and alcohol use impacted HCV treatment nonreferral through the mediation of not being engaged in HIV care. Achieving HCV elimination requires DAA treatment outside conventional health settings, including substance rehabilitation centers, mental health crisis houses, and homeless shelters.</description><identifier>ISSN: 0269-9370</identifier><identifier>EISSN: 1473-5571</identifier><identifier>DOI: 10.1097/QAD.0000000000002610</identifier><identifier>PMID: 32769765</identifier><language>eng</language><publisher>England: Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Antiviral Agents - therapeutic use ; California ; Coinfection - epidemiology ; Continuity of Patient Care ; Delivery of Health Care, Integrated - organization & administration ; Health Services Accessibility ; Hepacivirus - isolation & purification ; Hepatitis C - complications ; Hepatitis C - drug therapy ; Hepatitis C - epidemiology ; HIV Infections - complications ; HIV Infections - drug therapy ; HIV Infections - epidemiology ; Housing ; Humans ; Referral and Consultation - statistics & numerical data ; Substance-Related Disorders - complications</subject><ispartof>AIDS (London), 2020-09, Vol.34 (11), p.1681-1683</ispartof><rights>Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3982-63fbaa56c47a752bbd3d53a81c945c9b84516ae079524a7403c1a9d49082b2363</citedby><cites>FETCH-LOGICAL-c3982-63fbaa56c47a752bbd3d53a81c945c9b84516ae079524a7403c1a9d49082b2363</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32769765$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cachay, Edward R.</creatorcontrib><creatorcontrib>Torriani, Francesca J.</creatorcontrib><creatorcontrib>Hill, Lucas</creatorcontrib><creatorcontrib>Jain, Sonia</creatorcontrib><creatorcontrib>Del Real, Azucena</creatorcontrib><creatorcontrib>Qin, Huifang</creatorcontrib><creatorcontrib>Martin, Natasha</creatorcontrib><creatorcontrib>Mathews, William C.</creatorcontrib><title>The role of barriers to care on the propensity for hepatitis C virus nonreferral among people living with HIV</title><title>AIDS (London)</title><addtitle>AIDS</addtitle><description>Twenty-five percent of HIV/hepatitis C virus (HCV) coinfected patients were not referred for HCV treatment despite unrestricted access in California to direct-acting antivirals (DAA) in 2018. Having unstable housing and ongoing drug use directly affected HCV treatment nonreferral. However, psychiatric history and alcohol use impacted HCV treatment nonreferral through the mediation of not being engaged in HIV care. Achieving HCV elimination requires DAA treatment outside conventional health settings, including substance rehabilitation centers, mental health crisis houses, and homeless shelters.</description><subject>Antiviral Agents - therapeutic use</subject><subject>California</subject><subject>Coinfection - epidemiology</subject><subject>Continuity of Patient Care</subject><subject>Delivery of Health Care, Integrated - organization & administration</subject><subject>Health Services Accessibility</subject><subject>Hepacivirus - isolation & purification</subject><subject>Hepatitis C - complications</subject><subject>Hepatitis C - drug therapy</subject><subject>Hepatitis C - epidemiology</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - epidemiology</subject><subject>Housing</subject><subject>Humans</subject><subject>Referral and Consultation - statistics & numerical data</subject><subject>Substance-Related Disorders - complications</subject><issn>0269-9370</issn><issn>1473-5571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkGtLwzAUhoMobk7_gUj-QGeuTfNxzMsGAxGmX0vapjbaNiXJNvbvjc4bni-H857zvhweAC4xmmIkxfXj7GaK_hRJMToCY8wETTgX-BiMoyYTSQUagTPvX-MRR1l2CkaUiFSKlI9Bt240dLbV0NawUM4Z7TwMFpbKRa2HIe4HZwfdexP2sLYONnpQwQTj4Rxujdt42Nve6Vo7p1qoOtu_wEHbIYa2ZmvitDOhgYvl8zk4qVXr9cVXn4Cnu9v1fJGsHu6X89kqKanMSJLSulCKpyUTSnBSFBWtOFUZLiXjpSwyxnGqNBKSE6YEQ7TESlZMoowUhKZ0Atght3TW-_haPjjTKbfPMco_6OWRXv6fXrRdHWzDpuh09WP6xvWbu7NtiKDe2s1Ou7zRqg3NZx5BFCUkNiQRRklUMKHv-aN6Jw</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Cachay, Edward R.</creator><creator>Torriani, Francesca J.</creator><creator>Hill, Lucas</creator><creator>Jain, Sonia</creator><creator>Del Real, Azucena</creator><creator>Qin, Huifang</creator><creator>Martin, Natasha</creator><creator>Mathews, William C.</creator><general>Wolters Kluwer Health, Inc. All rights reserved</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20200901</creationdate><title>The role of barriers to care on the propensity for hepatitis C virus nonreferral among people living with HIV</title><author>Cachay, Edward R. ; Torriani, Francesca J. ; Hill, Lucas ; Jain, Sonia ; Del Real, Azucena ; Qin, Huifang ; Martin, Natasha ; Mathews, William C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3982-63fbaa56c47a752bbd3d53a81c945c9b84516ae079524a7403c1a9d49082b2363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antiviral Agents - therapeutic use</topic><topic>California</topic><topic>Coinfection - epidemiology</topic><topic>Continuity of Patient Care</topic><topic>Delivery of Health Care, Integrated - organization & administration</topic><topic>Health Services Accessibility</topic><topic>Hepacivirus - isolation & purification</topic><topic>Hepatitis C - complications</topic><topic>Hepatitis C - drug therapy</topic><topic>Hepatitis C - epidemiology</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - epidemiology</topic><topic>Housing</topic><topic>Humans</topic><topic>Referral and Consultation - statistics & numerical data</topic><topic>Substance-Related Disorders - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cachay, Edward R.</creatorcontrib><creatorcontrib>Torriani, Francesca J.</creatorcontrib><creatorcontrib>Hill, Lucas</creatorcontrib><creatorcontrib>Jain, Sonia</creatorcontrib><creatorcontrib>Del Real, Azucena</creatorcontrib><creatorcontrib>Qin, Huifang</creatorcontrib><creatorcontrib>Martin, Natasha</creatorcontrib><creatorcontrib>Mathews, William C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>AIDS (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cachay, Edward R.</au><au>Torriani, Francesca J.</au><au>Hill, Lucas</au><au>Jain, Sonia</au><au>Del Real, Azucena</au><au>Qin, Huifang</au><au>Martin, Natasha</au><au>Mathews, William C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of barriers to care on the propensity for hepatitis C virus nonreferral among people living with HIV</atitle><jtitle>AIDS (London)</jtitle><addtitle>AIDS</addtitle><date>2020-09-01</date><risdate>2020</risdate><volume>34</volume><issue>11</issue><spage>1681</spage><epage>1683</epage><pages>1681-1683</pages><issn>0269-9370</issn><eissn>1473-5571</eissn><abstract>Twenty-five percent of HIV/hepatitis C virus (HCV) coinfected patients were not referred for HCV treatment despite unrestricted access in California to direct-acting antivirals (DAA) in 2018. Having unstable housing and ongoing drug use directly affected HCV treatment nonreferral. However, psychiatric history and alcohol use impacted HCV treatment nonreferral through the mediation of not being engaged in HIV care. Achieving HCV elimination requires DAA treatment outside conventional health settings, including substance rehabilitation centers, mental health crisis houses, and homeless shelters.</abstract><cop>England</cop><pub>Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>32769765</pmid><doi>10.1097/QAD.0000000000002610</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0269-9370 |
| ispartof | AIDS (London), 2020-09, Vol.34 (11), p.1681-1683 |
| issn | 0269-9370 1473-5571 |
| language | eng |
| recordid | cdi_crossref_primary_10_1097_QAD_0000000000002610 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Antiviral Agents - therapeutic use California Coinfection - epidemiology Continuity of Patient Care Delivery of Health Care, Integrated - organization & administration Health Services Accessibility Hepacivirus - isolation & purification Hepatitis C - complications Hepatitis C - drug therapy Hepatitis C - epidemiology HIV Infections - complications HIV Infections - drug therapy HIV Infections - epidemiology Housing Humans Referral and Consultation - statistics & numerical data Substance-Related Disorders - complications |
| title | The role of barriers to care on the propensity for hepatitis C virus nonreferral among people living with HIV |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T09%3A44%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20barriers%20to%20care%20on%20the%20propensity%20for%20hepatitis%20C%20virus%20nonreferral%20among%20people%20living%20with%20HIV&rft.jtitle=AIDS%20(London)&rft.au=Cachay,%20Edward%20R.&rft.date=2020-09-01&rft.volume=34&rft.issue=11&rft.spage=1681&rft.epage=1683&rft.pages=1681-1683&rft.issn=0269-9370&rft.eissn=1473-5571&rft_id=info:doi/10.1097/QAD.0000000000002610&rft_dat=%3Cpubmed_cross%3E32769765%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32769765&rfr_iscdi=true |